- February 16, 2018: case count updated to 243
- January 23, 2018: Updated recommendations on infection prevention and control
- January 2, 2018: Stories From the Field – Stopping C. auris in an Oklahoma Hospital
- September 25, 2017: Clinical Update
- September 18, 2017: Updated recommendations on identification and treatment
- August 24, 2017: Medscape Commentary: The Unexpected and Troubling Rise of Candida auris
Candida auris is an emerging fungus that presents a serious global health threat. CDC is concerned about C. auris for three main reasons:
- It is often multidrug-resistant, meaning that it is resistant to multiple antifungal drugs commonly used to treat Candida infections.
- It is difficult to identify with standard laboratory methods, and it can be misidentified in labs without specific technology. Misidentification may lead to inappropriate management.
- It has caused outbreaks in healthcare settings. For this reason, it is important to quickly identify C. auris in a hospitalized patient so that healthcare facilities can take special precautions to stop its spread.
CDC encourages all U.S. laboratory staff who identify C. auris to notify their state or local public health authorities and CDC at firstname.lastname@example.org.
- Page last reviewed: November 4, 2016
- Page last updated: February 16, 2018
- Content source: